Steven Howard & Chris Abell 
Fragment-Based Drug Discovery [EPUB ebook] 

Apoio

Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is hoped that this approval is just the beginning of the many drugs yet to be discovered using this fascinating technique.

This book is written from a Chemist’s perspective and comprehensively assesses the impact of fragment-based drug discovery on a wide variety of areas of medicinal chemistry. It will prove to be an invaluable resource for medicinal chemists working in academia and industry, as well as anyone interested in novel drug discovery techniques.

€229.99
Métodos de Pagamento

Tabela de Conteúdo

Different flavours of Fragments; Advances in SPR Technology; Applications of NMR in Fragment-Based Drug Discovery; Issues around Fragments as an Approach, including a Computational/in silico Perspectives on Fragment-Based Drug Discovery; Fragment-Based Drug Discovery of Kinase Inhibitors; Fragment-Based Discovery of Antibacterials; Strategies for Fragment-Based Lead Generation; Fragment-Based Approaches to Epigenetic Targets; Application of Fragment-Based Drug Discovery to GPCRs; Fragment-Based Drug Discovery applied to Protein-Protein Interactions; Probing Difficult Targets

Compre este e-book e ganhe mais 1 GRÁTIS!
Língua Inglês ● Formato EPUB ● Páginas 314 ● ISBN 9781782625650 ● Tamanho do arquivo 5.9 MB ● Editor Steven Howard & Chris Abell ● Editora Royal Society of Chemistry ● Publicado 2015 ● Edição 1 ● Carregável 24 meses ● Moeda EUR ● ID 5495486 ● Proteção contra cópia Adobe DRM
Requer um leitor de ebook capaz de DRM

Mais ebooks do mesmo autor(es) / Editor

11.837 Ebooks nesta categoria